Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Learning from the COVID-19 pandemic to improve cancer treatments

Learning from the COVID-19 pandemic to improve cancer treatments

The novel coronavirus (SARS-CoV-2) outbreak and its consequences required urgent interventions in all sectors affecting society, including economic and social issues and particularly the healthcare sector, such as protecting the safety of patients and healthcare workers and minimizing disruptions to healthcare services.  

ASCO (American Society of Clinical Oncology) published a report evaluating adaptations in healthcare, research and observations in the responses developed against the coronavirus outbreak. The report contains recommendations for improving cancer care as the pandemic recedes.

ASCO prepared recommendations for clinical research around 5 goals to learn from the Covid-19 experience used to create a more equitable, accessible and effective clinical research system that protects patient safety, ensures scientific integrity and maintains data quality.

5 goals identified through lessons learned from Covid-19

  1. Provide accessible, affordable and equitable clinical research
  2. Design more pragmatic and effective clinical research
  3. Minimize administrative and regulatory burdens at research sites
  4. Develop, maintain and support a well-trained clinical research workforce
  5. Promote appropriate oversight and review of the conduct and results of clinical research.

ASCO also prepared recommendations for cancer care around 5 similar goals

  1. Ensure and maintain equity in access to high-quality cancer care
  2. Support the safe delivery of high-quality cancer care
  3. Develop policies to ensure that oncology services have sufficient resources to deliver high-quality cancer care
  4. Recognize and address threats to the well-being of doctors, professionals and patients
  5. Telemedicine as a means of improving patients' access to high-quality cancer care

Goals for cancer care

Ensure and maintain equity in access to high-quality cancer care

ASCO is extremely concerned about the disproportionate impact of Covid-19 on minority and low-income communities. As defined in ASCO's Policy Statement on Cancer Disparities and Health Equity, inequity in cancer care persistently continues. Persistent disparities in access to healthcare and outcomes are being exacerbated and further exposed by the pandemic.

The pandemic highlighted the greater need for health insurance and for patient assistance with out-of-pocket costs not covered by insurance. According to one analysis, an estimated 6.2 million people in the United States alone lost their employer-provided insurance because of the economic downturn. ASCO is pursuing state and federal policies that expand patients' access to public and private insurance, state and private insurance, and reduce out-of-pocket spending. The society actively opposes policies that would restrict access to public programs for patients with cancer, including requirements for quarantine periods and work requirements for medical assistance for people with low incomes. ASCO continues to oppose state policies supporting short-term, limited-duration and association health plans because they do not provide adequate coverage and are not subject to consumer protections under the Affordable Care Act.

Support the safe delivery of high-quality cancer care

As Covid-19 infection spread and "stay at home" warnings became more common, some saw treatment at home as a way to maintain continuity of care. There are insufficient data demonstrating the safety of administering cancer chemotherapy at home, and these data will be needed to determine the optimal requirements and strategies for safely delivering chemotherapy outside healthcare facilities. Given the need to travel to a clinic for treatment, the inability to assess treatment side effects during this time and the increase in wasted time, ASCO does not support the routine use of anticancer treatments at home.

Another concern is the lack of a national strategy to ensure adequate supplies of essential equipment, treatment supplies and other materials that are difficult to obtain during the pandemic. In the absence of necessary assistance from national and state agencies, hospitals and other institutions are using their own creativity and resources to address supplies of Personal Protective Equipment (KKE). The government's struggle to obtain and distribute KKE raises sharp and clear concerns about government agencies' ability to distribute vaccines and new treatments equitably. In this report, ASCO offers recommendations for allocating scarce supplies.

Develop policies to ensure that oncology services have sufficient resources to deliver high-quality cancer care

The pandemic has had a profound impact on the economic well-being of many actors in the healthcare system, including cancer care services. Pandemic-related economic assistance and policies need to be expanded and made permanent to support a sustainable recovery process for cancer care services.

Pandemic-related changes implemented by cancer clinicians may remain in place in the near future (for example, social distancing, extended working hours and pre-screening visits). These important measures have imposed additional financial burdens, particularly in underserved areas. Programs developed for these circumstances need to be expanded with fewer restrictions and flexible terms to better meet the needs of oncology services.

Recognize and address threats to the well-being of clinicians, professionals and patients

The Covid-19 outbreak devastated families in many ways, including the negative psychological effects of quarantine and isolation, economic hardship and increased levels of anxiety and stress (see Psychological enemies of patients with cancer during the coronavirus pandemic). Many patients and caregivers lost their jobs. Working parents came under additional stress. Similar stresses also affect the well-being of healthcare services and clinicians.

Threats to patients' well-being arise from the stress of a cancer diagnosis, the difficulties of treatment and ongoing concerns during survivorship. The pandemic restricted access to certain services. Patients reported reduced access to support systems for medication-related problems and to treatment options, and that they could not do many things normally recommended to them (sleep more, experience less stress and exercise much, much more). Patients also lost access to childcare, caregiver support and many other resources because of the pandemic and the subsequent economic downturn.

In addition to personal or family concerns, clinicians also face difficulties in adapting cancer treatment during a crisis, concerns about shortages of medicines and equipment, and rapidly changing rules and regulations regarding safety and the requirements of providing healthcare (for example Delivering palliative care to patients with cancer through TELEHEALTH). All healthcare workers have been emotionally and physically harmed, whether or not they are directly involved with patients with Covid-19. There are concerns that such burdens will worsen burnout in the future and increase departures from oncology. Mental health and peer support will be crucial to maintaining and improving the well-being of healthcare providers. ASCO is committed to deepening its understanding of the needs of the oncology workforce to develop new strategies and approaches to help prevent such outcomes.  

Improve patients' access to high-quality cancer care through telemedicine

Telemedicine, defined as the use of technology and telecommunications systems to provide treatment to patients who are geographically distant from where healthcare services are delivered, appears to have been central to our healthcare system's responses to Covid-19.

Communicating with patients, relatives and caregivers over the internet or telephone requires healthcare workers to develop new communication skills. Telemedicine makes it difficult to use the usual tools of patient interactions: observing body language and making eye contact. Additional education and training in this area will allow patients as well as healthcare workers at all levels of practice and experience to benefit. However, research is also needed on issues such as the impact on vulnerable communities, the cost to patients and the effect on patients, and possible disruptions during licensing and referral. For this reason, ASCO created a Covid-19 registry to collect data that could benefit these areas. As the cancer care community establishes appropriate uses and standards for delivering care through telemedicine, healthcare workers will need this training.

Conclusion

The Covid-19 outbreak created many unprecedented and unexpected challenges, but it also revealed opportunities to improve patients' access to high-quality cancer care and research. This report is a roadmap of actions that healthcare systems and other organizations in the field can take to help improve access to affordable and equitable care and clinical research, streamline excessive and unnecessary regulatory requirements in practice and research, and achieve better outcomes for patients with cancer.

The pandemic is not yet over, and only time will tell how much this Covid-19 experience will reshape healthcare in Türkiye and around the world. ASCO will continue its practical work to prepare for future crises, assess ongoing challenges and opportunities, analyze emerging data and respond to emerging policies.

Sources

Pennell N. A. et al. (2021, Feb 22). American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care. Journal of Clinic Oncology: https://ascopubs.org/ retrieved

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Learning from the COVID-19 pandemic to improve cancer treatments

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy